Cargando…
The APRN's complete guide to prescribing drug therapy 2017 /
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
New York, NY :
Springer Publishing Company, LLC,
[2017]
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Cover; Title; Copyright; Contents; Reviewers; Abbreviations; Preface; Acknowledgments; Share The APRN's Complete Guide to Prescribing Drug Therapy 2017; Section I: Drug Therapy by Clinical Diagnosis; Acetaminophen Overdose; Antidote/Chelating Agent; Acne Rosacea; Topical Alpha-2 Agonist; Topical Antimicrobials; Oral Antimicrobials; Acne Vulgaris; Antibacterial Soaps; Topical Antimicrobials; Oral Antimicrobials; Topical Retinoids; Topical Retinoid/Antimicrobial Combinations; Oral Retinoid; Oral Contraceptives; Acromegaly; Growth Hormone Receptor Antagonist; Actinic Keratosis
- Alcohol Dependence/Alcohol Withdrawal SyndromeAlcohol Withdrawal Syndrome; Abstinence Therapy; Aversion Therapy; Allergic Reaction: General; Parenteral Antihistamine; Alzheimer's Disease; Nutritional Supplement; Reversible Anticholinesterase Inhibitors (RAIs); N-Methyl-D-Aspartate (NMDA) Receptor Antagonist; N-Methyl-D-Aspartate (NMDA) Receptor Antagonist/Acetylcholin-Esterase Inhibitor Combination; Ergot Alkaloid (Dopamine Agonist); Amebiasis; Amebiasis (Intestinal); Amebiasis (Extraintestinal); Amebic Liver Abscess; Anti-Infectives; Amenorrhea: Secondary; Anaphylaxis
- Anaphylaxis Emergency Treatment KitsAnemia of Chronic Kidney Disease (CKD) and Chronic Renal Failure (CRF); Erythropoiesis Stimulating Agents (ESAs); Erythropoietin Human, Recombinant; Anemia: Folic Acid Deficiency; Anemia: Iron Deficiency; Iron Preparations; Anemia: Megaloblastic/Anemia: Pernicious; Angina Pectoris: Stable; Calcium Antagonists; Beta-Blockers; Nitrates; Non-Nitrate Peripheral Vasodilator; Nitrate/Peripheral Vasodilator Combination; Non-Nitrate Anti-Anginal; Anorexia/Cachexia; Appetite Stimulants; Anthrax (Bacillus Anthracis)
- Postexposure Prophylaxis of Inhalational Anthrax and Treatment of Inhaled and Cutaneous Anthrax InfectionImmune Globulin; Treatment of Inhalational, GI, and Oropharyngeal Anthrax; Anxiety Disorder: Generalized (GAD)/Anxiety Disorder: Social (SAD); 1st Generation Antihistamine; Azaspirones; Benzodiazepines; Tricyclic Antidepressants (TCAs); Phenothiazines; Selective Serotonin Reuptake Inhibitors (SSRIs); Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs); Combination Agents; Aphthous Stomatitis (Mouth Ulcer, Canker Sore); Anti-Inflammatory Agents; Topical Anesthetics
- Debriding Agent/CleanserAnti-Infectives; Aspergillosis (Scedosporium Apiospermum, Fusarium SPP.); Invasive Infection; Asthma; Leukotriene Receptor Antagonists (LRAs); IGE Blocker (IGG1K Monoclonal Antibody); Inhaled Anticholinergics; Inhaled Corticosteroids; Inhaled Mast Cell Stabilizers (Prophylaxis); Inhaled Beta Agonists (Bronchodilators); Inhaled Racepinephrine (Bronchodilator); Inhaled Long-Acting Anticholinergic; Inhaled Anticholinergic/Beta Agonist; Inhaled Beta Agonist (Long-Acting) (LABA); Corticosteroid/Inhaled Long-Acting Beta Agonist (LABA); Oral Beta2-Agonists (Bronchodilators)